Daniel Lee Flynn

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Waltham, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Daniel Lee Flynn

Form 4 holding Chief Scientific Officer

Deciphera Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
180,947
Estimated value
$2,618,249
Report date
16 Jun 2023
Price
$14.47
Ownership
By Daniel L. Flynn Revocable Trust
Form 4 holding Chief Scientific Officer

Deciphera Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
91,020
Estimated value
$1,317,032
Report date
16 Jun 2023
Price
$14.47
Ownership
By Daniel L. Flynn Irrevocable Trust

Insider Reports Filed by Daniel Lee Flynn

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .